153 related articles for article (PubMed ID: 34966648)
1. Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease.
Zhang Q; Peng H; Liu X; Wang H; Du J; Luo X; Ren H; Hu P
J Clin Transl Hepatol; 2021 Dec; 9(6):850-859. PubMed ID: 34966648
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.
Kim TS; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
J Gastroenterol Hepatol; 2019 Nov; 34(11):2028-2035. PubMed ID: 31157456
[TBL] [Abstract][Full Text] [Related]
3. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
Kim JH; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2017 Aug; 66(2):335-343. PubMed ID: 28012257
[TBL] [Abstract][Full Text] [Related]
4. Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
Huang DQ; Tamaki N; Lee HW; Park SY; Lee YR; Lee HW; Lim SG; Lim TS; Kurosaki M; Marusawa H; Mashiba T; Kondo M; Uchida Y; Kobashi H; Furuta K; Izumi N; Kim BK; Sinn DH
Hepatology; 2023 May; 77(5):1746-1756. PubMed ID: 36633913
[TBL] [Abstract][Full Text] [Related]
5. Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
Lee HW; Park SY; Lee YR; Lee H; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
Am J Gastroenterol; 2022 Feb; 117(2):288-294. PubMed ID: 34506308
[TBL] [Abstract][Full Text] [Related]
6. Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis.
Yang J; Choi WM; Shim JH; Lee D; Kim KM; Lim YS; Lee HC; Choi J
Am J Gastroenterol; 2023 Jun; 118(6):1010-1018. PubMed ID: 36622283
[TBL] [Abstract][Full Text] [Related]
7. Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir.
Lee SB; Jeong J; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW; Park BR; Park EJ; Park NH
Clin Mol Hepatol; 2020 Jul; 26(3):364-375. PubMed ID: 32466635
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
[TBL] [Abstract][Full Text] [Related]
9. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
[TBL] [Abstract][Full Text] [Related]
10. Elevated hepatitis B virus RNA levels in HBeAg-positive patients with low-level viraemia or previous low-level viraemia.
Li T; Chen Y; Zhang Y; Wu S; Zhang L; Wang L
J Viral Hepat; 2024 Jun; ():. PubMed ID: 38855857
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage.
Yin GQ; Li J; Zhong B; Yang YF; Wang MR
World J Gastroenterol; 2021 Feb; 27(8):666-676. PubMed ID: 33716446
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL.
Lee H; Jang S; Ahn SH; Kim BK
Hepatol Int; 2022 Apr; 16(2):294-305. PubMed ID: 35322374
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia.
Wang X; Liu X; Wang P; Yu L; Yan F; Yan H; Zhou D; Yang Z
J Hepatocell Carcinoma; 2021; 8():1253-1267. PubMed ID: 34708007
[TBL] [Abstract][Full Text] [Related]
14. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
15. An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia.
Lee HW; Park SY; Lee M; Lee EJ; Lee J; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
Liver Int; 2020 Jul; 40(7):1736-1743. PubMed ID: 32239602
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.
Gordon SC; Lamerato LE; Rupp LB; Li J; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Vijayadeva V; Boscarino JA; Henkle EM; Oja-Tebbe N; Lu M;
Clin Gastroenterol Hepatol; 2014 May; 12(5):885-93. PubMed ID: 24107395
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
[TBL] [Abstract][Full Text] [Related]
18. Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization.
Jin M; Chen Y; Hu S; Zhu M; Wang Y; Chen M; Peng Z
Front Oncol; 2021; 11():751777. PubMed ID: 34745980
[TBL] [Abstract][Full Text] [Related]
19. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
Gaifer Z; Boulassel MR
J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.
Yip TC; Wong VW; Chan HL; Tse YK; Lui GC; Wong GL
Gastroenterology; 2020 Jan; 158(1):215-225.e6. PubMed ID: 31574268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
